Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies

被引：4
|
作者：
Di Minno, Matteo Nicola Dario [1 ]
Minno, Alessandro Di [2 ]
Calcaterra, Ilenia [3 ]
Cimino, Ernesto [3 ]
Dell'Aquila, Francesco [3 ]
Franchini, Massimo [4 ]
机构：
[1] Univ Naples Federico II, Dept Translat Med Sci, Via S Pansini 5, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dipartimento Farm, Naples, Italy
[3] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy
[4] Carlo Poma Hosp, Dept Haematol & Transfus Med, Mantua, Italy
来源：
SEMINARS IN THROMBOSIS AND HEMOSTASIS | 2022年 / 48卷 / 02期
关键词：
D O I：
10.1055/s-0041-1740148
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：253 / 255
页数：3
相关论文
共 50 条
  • [1] Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies
    Di Minno, Matteo Nicola Dario
    Di Minno, Alessandro
    Calcaterra, Ilenia
    Cimino, Ernesto
    Dell'Aquila, Francesco
    Franchini, Massimo
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2021, 47 (01): : 32 - 42
  • [2] Comment on "Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies"
    Horneff, Regina
    Bystricka, Linda
    Santagostino, Elena
    Lethagen, Stefan
    Casiano, Sandra
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2022, 48 (02): : 251 - 252
  • [3] Coagulopathy Hemophilia A: recombinant Factor VIII with long Half-life
    Weber, Christian
    TRANSFUSIONSMEDIZIN, 2014, 4 (02) : 63 - 63
  • [4] COST OF STANDARD HALF-LIFE VERSUS EXTENDED HALF-LIFE RECOMBINANT COAGULATION FACTOR VIII IN PATIENTS WITH HEMOPHILIA A IN SPAIN: RESULTS FROM A PROBABILISTIC MODEL
    Peral, C.
    Kim, H. K.
    Rubio-Rodriguez, D.
    Rubio Terres, C.
    VALUE IN HEALTH, 2019, 22 : S421 - S422
  • [5] Half-life extended factor VIII for the treatment of hemophilia A
    Tiede, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : S176 - S179
  • [6] Extended half-life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products
    Teitel, Jerome
    Sholzberg, Michelle
    Iorio, Alfonso
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2021, 5 (02) : 349 - 355
  • [7] Enhanced pharmacokinetics and reduced bleeds in boys with hemophilia A after switching to Kovaltry from other standard half-life factor VIII concentrates
    Huang, Kun
    Zhen, Yingzi
    Li, Gang
    Wu, Xinyi
    Chen, Zhenping
    Wu, Runhui
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (02)
  • [8] HEAT INACTIVATION OF EXTENDED HALF-LIFE FACTOR VIII CONCENTRATES
    Fylling, Kara A.
    Tange, Julie I.
    Chen, Dong
    Pruthi, Rajiv K.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E20 - E20
  • [9] Heat inactivation of extended half-life factor VIII concentrates
    Fylling, Kara A.
    Tange, Julie I.
    Chen, Dong
    Pruthi, Rajiv K.
    HAEMOPHILIA, 2019, 25 (02) : E130 - E131
  • [10] Comparison of the Pharmacokinetic Properties of Extended Half-Life and Recombinant Factor VIII Concentrates by In Silico Simulations
    Bukkems, Laura H.
    Preijers, Tim
    van Spengler, Max W. F.
    Leebeek, Frank W. G.
    Cnossen, Marjon H.
    Mathot, Ron A. A.
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (06) : 731 - 740
12345